Observational studyTargeted oncology2022

Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer.

Gianluca Arrichiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.